{
  "id": 18132100,
  "title": "Boehringer Ingelheim strikes $7B backloaded ADC, TCE cancer deal with China's Sino",
  "url": "https://urgent.news/2026/11/04/boehringer-ingelheim-strikes-7b-backloaded-adc-tce-cancer-deal-with",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-04T13:57:21.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/boehringer-ingelheim-strikes-7b-backloaded-adc-tce-cancer-deal-with-chinas-sino/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Germany's Boehringer Ingelheim is further planting its stake in China, teaming up with Sino Biopharmaceutical in a cancer drug development deal that could balloon past $7 billion. Boehringer is delivering $358 million ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}